Clear Investment Research »

Intellia Therapeutics shares owned by Clear Investment Research

Quarter-by-quarter ownership of Intellia Therapeutics (NTLA) shares owned by Clear Investment Research from 13F filings

Historical chart of Clear Investment Research investment in Intellia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Intellia Therapeutics held by Clear Investment Research consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intellia Therapeutics by Clear Investment Research

Quarter filed Position value Share count Share price at filing
2023-12-31 $334 11 30.45

More positions owned by Clear Investment Research

Ishares Tr Core S&p500 Etf (IVV)
Graphic Packaging Holding Company (GPK)
Ishares Tr Core S&p Mcp Etf (IJH)
Vanguard Index Fds Real Estate Etf (VNQ)
Vaneck Vectors Etf Tr Fallen Angel Hg (ANGL)
Ishares Tr Cores Msci Eafe (IEFA)
Fidelity Merrimack Str Tr Total Bd Etf (FBND)
Scwab Strategic Tr Us Lrg Cap Etf (SCHX)
Apple (AAPL)
Ishares Tr Core S&p Scp Etf (IJR)
Ishares Core Msci Emkt (IEMG)
Eli Lilly & Co. (LLY)
Microsoft Corporation (MSFT)
Scwab Strategic Tr Sht Tm Us Tres (SCHO)
Ishares Tr S&p 500 Val Etf (IVE)

View all positions for Clear Investment Research

Top funds holding Intellia Therapeutics

ARK Investment Management
Vanguard Group
Nikko Asset Management Americas
Sumitomo Mitsui Trust Holdings
Wellington Management Company
Federated Investors
T. Rowe Price Associates
Alliancebernstein
Citadel Advisors
Rokos Capital Management
Casdin Capital
Dimensional Fund Advisors
Chevy Chase Trust Holdings
Marshall Wace
Goldman Sachs Group

View all funds holding Intellia Therapeutics